Skip to main content
Premium Trial:

Request an Annual Quote

OriCiro Genomics: Shige Sasaki, Nasir Kato Bashiruddin

Tokyo-based Synthetic biology firm OriCiro Genomics has appointed Shigemasa (Shige) Sasaki as chief operating officer and chief business officer, and Nasir Kato Bashiruddin as chief technology officer.

Prior to joining OriCiro, Sasaki was president of the Japanese subsidiary of Unchained Labs, a US-based research tools company. Before that, he was Asia Pacific marketing director at GE Healthcare. He holds a BS in bioengineering from Fukui Prefectural University.

Bashiruddin used to be director of the platform innovation group at PeptiDream, a peptide drug discovery firm. He holds a PhD in chemistry from the University of Tokyo and a BS in biology from the University of Washington.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.